Clinical Trial Update: T900607 in Treating Patients With Unresectable Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of T900607 for unresectable liver cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• T900607

Snippet

Sponsor: University Hospitals Seidman Cancer Center | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED